Department of Urology, Naval Medical Center San Diego, San Diego, CA, USA.
Department of Urology, UC San Diego Health System, La Jolla, CA, USA.
World J Urol. 2017 Nov;35(11):1721-1728. doi: 10.1007/s00345-017-2062-0. Epub 2017 Jun 27.
We compared quality outcomes between transperitoneal (TRPN) and retroperitoneal robotic partial nephrectomy (RRPN).
Two-center retrospective analysis of TRPN and RRPN from 10/2009 to 10/2015. Perioperative/renal function outcomes were analyzed. Primary endpoint was Pentafecta, a composite measure of quality [negative margin, no 30-day complication, ischemia time ≤25 min, return of glomerular filtration rate (eGFR) to >90% from baseline at last follow-up, and no chronic kidney disease upstaging]. Multivariable analysis (MVA) for factors associated with lack of optimal outcome was performed.
404 patients (TRPN 263, RRPN 141) were analyzed. Comparing TRPN vs. RRPN, mean tumor size (3.1 vs. 2.9 cm, p = 0.122) and RENAL score (7.4 vs. 7.2, p = 0.503) were similar. Most TRPN were anterior (65.0%) and most RRPN posterior (65.3%, p < 0.001). Operative time (p = 0.001) was less for RRPN. No significant differences between TRPN vs. RRPN were noted for ischemia time (23.1 vs. 22.8 min, p = 0.313), blood loss (p = 0.772), positive margins (p = 0.590), complications (p = 0.537), length of stay (p = 0.296), ΔeGFR (p = 0.246), eGFR recovery to >90% (55.9 vs. 57.4%, p = 0.833), and lack of CKD upstaging (84.0 vs. 87.2%, p = 0.464). Pentafecta rates were not significantly different (TRPN 33.9 vs. RRPN 43.3%, p = 0.526). MVA revealed increasing RENAL score (OR 1.5, p < 0.001) and decreasing baseline eGFR (OR 2.4, p = 0.017) as predictive for lack of Pentafecta.
TRPN and RRPN have similar quality outcomes, though RRPN may offer modest benefit for operative time and have utility in posterior tumors. Association of increasing RENAL score and decreased baseline eGFR with lack of Pentafecta suggests dominant role of non-modifiable factors.
我们比较了经腹腔(TRPN)和后腹腔镜机器人部分肾切除术(RRPN)之间的质量结果。
对 2009 年 10 月至 2015 年 10 月期间进行的 TRPN 和 RRPN 的双中心回顾性分析。分析围手术期/肾功能结果。主要终点是 Pentafecta,这是一种质量综合指标[阴性边缘、30 天内无并发症、缺血时间≤25 分钟、最后一次随访时肾小球滤过率(eGFR)从基线恢复至>90%、无慢性肾脏病升级]。对与缺乏最佳结果相关的因素进行多变量分析(MVA)。
分析了 404 例患者(TRPN 263 例,RRPN 141 例)。与 TRPN 相比,RRPN 的平均肿瘤大小(3.1 对 2.9cm,p=0.122)和 RENAL 评分(7.4 对 7.2,p=0.503)相似。大多数 TRPN 为前位(65.0%),而大多数 RRPN 为后位(65.3%,p<0.001)。RRPN 的手术时间(p=0.001)更短。与 TRPN 相比,RRPN 的缺血时间(23.1 对 22.8 分钟,p=0.313)、出血量(p=0.772)、阳性边缘(p=0.590)、并发症(p=0.537)、住院时间(p=0.296)、ΔeGFR(p=0.246)、eGFR 恢复至>90%(55.9%对 57.4%,p=0.833)和无慢性肾脏病升级(84.0%对 87.2%,p=0.464)均无显著差异。Pentafecta 率无显著差异(TRPN 33.9%对 RRPN 43.3%,p=0.526)。MVA 显示,RENAL 评分增加(OR 1.5,p<0.001)和基线 eGFR 降低(OR 2.4,p=0.017)是 Pentafecta 缺乏的预测因素。
TRPN 和 RRPN 的质量结果相似,尽管 RRPN 可能在手术时间上具有一定优势,并且在后位肿瘤中具有实用性。RENAL 评分增加和基线 eGFR 降低与 Pentafecta 缺乏的关联表明,非可改变因素起主导作用。